US Stock MarketDetailed Quotes

Mirum Pharmaceuticals (MIRM)

Watchlist
  • 91.850
  • -0.470-0.51%
Trading Jan 16 15:00 ET
4.75BMarket Cap-109.35P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mirum Pharmaceuticals (MIRM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
47.17%133.01M
64.09%127.79M
61.20%111.59M
80.76%336.89M
42.93%99.41M
89.37%90.38M
107.68%77.88M
119.07%69.22M
141.85%186.37M
149.24%69.55M
Operating revenue
47.17%133.01M
64.09%127.79M
61.20%111.59M
80.76%336.89M
42.93%99.41M
89.37%90.38M
107.68%77.88M
119.07%69.22M
141.85%186.37M
149.24%69.55M
Cost of revenue
22.74%25.54M
15.79%23.42M
29.10%23.02M
73.56%81.64M
-8.95%22.78M
103.42%20.81M
196.93%20.23M
258.10%17.83M
280.14%47.04M
456.74%25.02M
Gross profit
54.48%107.47M
81.04%104.36M
72.34%88.57M
83.19%255.25M
72.08%76.63M
85.54%69.57M
87.87%57.65M
93.07%51.39M
115.40%139.34M
90.22%44.53M
Operating expense
27.49%104.87M
33.55%109.35M
33.25%103.75M
37.97%342.85M
30.78%100.86M
31.30%82.26M
48.99%81.88M
44.81%77.86M
26.84%248.49M
33.95%77.12M
Selling and administrative expenses
22.48%61.91M
28.61%63.29M
26.44%57.71M
38.62%202.22M
23.05%56.83M
38.37%50.55M
49.35%49.21M
51.02%45.64M
63.79%145.88M
74.49%46.18M
Research and development costs
35.48%42.96M
41.00%46.07M
42.90%46.04M
37.05%140.63M
42.32%44.03M
21.42%31.71M
48.45%32.67M
36.84%32.22M
-3.96%102.61M
-0.55%30.94M
Operating profit
120.52%2.6M
79.41%-4.99M
42.64%-15.18M
19.74%-87.61M
25.67%-24.22M
49.56%-12.68M
0.17%-24.23M
2.50%-26.47M
16.82%-109.15M
4.61%-32.59M
Net non-operating interest income expense
-203.42%-355K
-569.88%-556K
-1,123.21%-573K
62.12%-519K
-276.89%-375K
-124.02%-117K
16.16%-83K
102.84%56K
88.70%-1.37M
109.57%212K
Non-operating interest income
-6.28%3.25M
-12.99%3.03M
-16.79%3.02M
0.41%13.79M
-15.13%3.2M
-14.58%3.47M
-3.89%3.49M
59.90%3.63M
256.11%13.74M
76.15%3.78M
Non-operating interest expense
0.56%3.61M
0.56%3.59M
0.53%3.6M
-5.26%14.31M
0.45%3.58M
0.34%3.59M
-4.21%3.57M
-15.68%3.58M
-5.47%15.11M
-18.26%3.56M
Other net income (expense)
136.34%395K
-72.44%86K
19.98%2.11M
102.34%1.21M
107.55%231K
-182.22%-1.09M
100.63%312K
316.65%1.76M
-4,183.40%-51.9M
-3,659.30%-3.06M
Special income (charges)
----
----
----
--0
--0
--0
--0
----
---49.08M
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
--49.08M
--0
Other non- operating income (expenses)
136.34%395K
-72.44%86K
19.98%2.11M
142.95%1.21M
107.55%231K
-182.22%-1.09M
213.87%312K
316.65%1.76M
-873.70%-2.82M
-420.58%-3.06M
Income before tax
119.03%2.64M
77.26%-5.46M
44.64%-13.65M
46.49%-86.91M
31.24%-24.37M
40.49%-13.89M
67.44%-24M
17.62%-24.66M
-14.33%-162.42M
2.36%-35.43M
Income tax
-175.50%-262K
-36.69%402K
64.90%1.03M
3.94%1.03M
-356.00%-576K
39.36%347K
100.95%635K
210.45%624K
115.47%991K
60.71%225K
Net income
120.41%2.91M
76.21%-5.86M
41.94%-14.68M
46.18%-87.94M
33.28%-23.79M
39.65%-14.24M
66.72%-24.64M
16.10%-25.28M
-20.45%-163.42M
2.12%-35.66M
Net income continuous Operations
120.41%2.91M
76.21%-5.86M
41.94%-14.68M
46.18%-87.94M
33.28%-23.79M
39.65%-14.24M
66.72%-24.64M
16.10%-25.28M
-20.45%-163.42M
2.12%-35.66M
Minority interest income
Net income attributable to the parent company
120.41%2.91M
76.21%-5.86M
41.94%-14.68M
46.18%-87.94M
33.28%-23.79M
39.65%-14.24M
66.72%-24.64M
16.10%-25.28M
-20.45%-163.42M
2.12%-35.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
120.41%2.91M
76.21%-5.86M
41.94%-14.68M
46.18%-87.94M
33.28%-23.79M
39.65%-14.24M
66.72%-24.64M
16.10%-25.28M
-20.45%-163.42M
2.12%-35.66M
Basic earnings per share
120.00%0.06
76.92%-0.12
44.44%-0.3
53.75%-1.85
30.63%-0.4922
47.37%-0.3
73.20%-0.52
32.50%-0.54
0.25%-4
28.03%-0.7095
Diluted earnings per share
116.67%0.05
76.92%-0.12
44.44%-0.3
53.75%-1.85
30.63%-0.4922
47.37%-0.3
73.20%-0.52
32.50%-0.54
0.50%-4
28.03%-0.7095
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 47.17%133.01M64.09%127.79M61.20%111.59M80.76%336.89M42.93%99.41M89.37%90.38M107.68%77.88M119.07%69.22M141.85%186.37M149.24%69.55M
Operating revenue 47.17%133.01M64.09%127.79M61.20%111.59M80.76%336.89M42.93%99.41M89.37%90.38M107.68%77.88M119.07%69.22M141.85%186.37M149.24%69.55M
Cost of revenue 22.74%25.54M15.79%23.42M29.10%23.02M73.56%81.64M-8.95%22.78M103.42%20.81M196.93%20.23M258.10%17.83M280.14%47.04M456.74%25.02M
Gross profit 54.48%107.47M81.04%104.36M72.34%88.57M83.19%255.25M72.08%76.63M85.54%69.57M87.87%57.65M93.07%51.39M115.40%139.34M90.22%44.53M
Operating expense 27.49%104.87M33.55%109.35M33.25%103.75M37.97%342.85M30.78%100.86M31.30%82.26M48.99%81.88M44.81%77.86M26.84%248.49M33.95%77.12M
Selling and administrative expenses 22.48%61.91M28.61%63.29M26.44%57.71M38.62%202.22M23.05%56.83M38.37%50.55M49.35%49.21M51.02%45.64M63.79%145.88M74.49%46.18M
Research and development costs 35.48%42.96M41.00%46.07M42.90%46.04M37.05%140.63M42.32%44.03M21.42%31.71M48.45%32.67M36.84%32.22M-3.96%102.61M-0.55%30.94M
Operating profit 120.52%2.6M79.41%-4.99M42.64%-15.18M19.74%-87.61M25.67%-24.22M49.56%-12.68M0.17%-24.23M2.50%-26.47M16.82%-109.15M4.61%-32.59M
Net non-operating interest income expense -203.42%-355K-569.88%-556K-1,123.21%-573K62.12%-519K-276.89%-375K-124.02%-117K16.16%-83K102.84%56K88.70%-1.37M109.57%212K
Non-operating interest income -6.28%3.25M-12.99%3.03M-16.79%3.02M0.41%13.79M-15.13%3.2M-14.58%3.47M-3.89%3.49M59.90%3.63M256.11%13.74M76.15%3.78M
Non-operating interest expense 0.56%3.61M0.56%3.59M0.53%3.6M-5.26%14.31M0.45%3.58M0.34%3.59M-4.21%3.57M-15.68%3.58M-5.47%15.11M-18.26%3.56M
Other net income (expense) 136.34%395K-72.44%86K19.98%2.11M102.34%1.21M107.55%231K-182.22%-1.09M100.63%312K316.65%1.76M-4,183.40%-51.9M-3,659.30%-3.06M
Special income (charges) --------------0--0--0--0-------49.08M--0
-Less:Other special charges ----------------------------------49.08M--0
Other non- operating income (expenses) 136.34%395K-72.44%86K19.98%2.11M142.95%1.21M107.55%231K-182.22%-1.09M213.87%312K316.65%1.76M-873.70%-2.82M-420.58%-3.06M
Income before tax 119.03%2.64M77.26%-5.46M44.64%-13.65M46.49%-86.91M31.24%-24.37M40.49%-13.89M67.44%-24M17.62%-24.66M-14.33%-162.42M2.36%-35.43M
Income tax -175.50%-262K-36.69%402K64.90%1.03M3.94%1.03M-356.00%-576K39.36%347K100.95%635K210.45%624K115.47%991K60.71%225K
Net income 120.41%2.91M76.21%-5.86M41.94%-14.68M46.18%-87.94M33.28%-23.79M39.65%-14.24M66.72%-24.64M16.10%-25.28M-20.45%-163.42M2.12%-35.66M
Net income continuous Operations 120.41%2.91M76.21%-5.86M41.94%-14.68M46.18%-87.94M33.28%-23.79M39.65%-14.24M66.72%-24.64M16.10%-25.28M-20.45%-163.42M2.12%-35.66M
Minority interest income
Net income attributable to the parent company 120.41%2.91M76.21%-5.86M41.94%-14.68M46.18%-87.94M33.28%-23.79M39.65%-14.24M66.72%-24.64M16.10%-25.28M-20.45%-163.42M2.12%-35.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 120.41%2.91M76.21%-5.86M41.94%-14.68M46.18%-87.94M33.28%-23.79M39.65%-14.24M66.72%-24.64M16.10%-25.28M-20.45%-163.42M2.12%-35.66M
Basic earnings per share 120.00%0.0676.92%-0.1244.44%-0.353.75%-1.8530.63%-0.492247.37%-0.373.20%-0.5232.50%-0.540.25%-428.03%-0.7095
Diluted earnings per share 116.67%0.0576.92%-0.1244.44%-0.353.75%-1.8530.63%-0.492247.37%-0.373.20%-0.5232.50%-0.540.50%-428.03%-0.7095
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.26%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.42%
4
Broadcom
AVGO
+1.80%
5
Block
XYZ
+1.32%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.63%
Sample Name
Sample Code
 +10.45%
Sample Name
Sample Code
 +10.01%
4
Kingsoft Cloud
KC
+7.08%
5
Taiwan Semiconductor
TSM
+6.12%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -